OVERVIEW
The global market for in vitro diagnostics is expected to hit USD 72.3 billion by 2025, growing to CAGR 4.71% over the forecast period. The major factors that are expected to drive the demand for in vitro diagnostics are the geriatric population and the resulting increase in the prevalence of chronic and infectious diseases, increasing the adoption of fully automated instruments, and laboratory automation.








TABLE OF CONTENT
1 Global In Vitro Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global In Vitro Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global In Vitro Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global In Vitro Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global In Vitro Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global In Vitro Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global In Vitro Diagnostics Market – By Product & Service (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
8.3 Data Management Software
8.4 Services
9 Global In Vitro Diagnostics Market – By Technology
9.1 Immunochemistry/Immunoassay
9.2 Hematology
9.3 Coagulation & Hemostasis
9.4 Molecular Diagnostics
9.5 Clinical Chemistry
9.6 Microbiology
9.7 Urinalysis
9.8 Others
10 Global In Vitro Diagnostics Market – By Application
10.1 Autoimmune Diseases
10.2 Drug Testing/Pharmacogenomics
10.3 Infectious Diseases
10.4 Cardiology
10.5 Diabetes
10.6 Nephrology
10.7 HIV/AIDS
10.8 Oncology/Cancer
10.9 Others
11 Global In Vitro Diagnostics Market – By End-User
11.1 Laboratories
11.2 Point-Of-Care Testing
11.3 Patient Self-Testing
11.4 Hospitals
11.5 Academics
11.6 Others
12 Global In Vitro Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global In Vitro Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global In Vitro Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories, Inc.
14.3 Johnson & Johnson
14.4 Roche Diagnostics
14.5 Danaher Corporation
14.6 Agilent Technologies
14.7 Siemens AG
14.8 Becton, Dickinson and Company
14.9 Biomérieux Sa
14.10 Thermo Fisher Scientific
14.11 Bio-Rad Laboratories, Inc.
14.12 Company 11 & more
15 Global In Vitro Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations